Resistell Ag
Resistell is a antibiotic resistance test.
Resistell Ag has raised €6.5M across 2 funding rounds from 1 investor, most recently a Series A round in Jan 2020. Based in Basel, Switzerland; founded 2018; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€6.5M
€6,475,291
Funding rounds
2
Investors
1
distinct backers
Active since
2020-01
latest 2020-01
Funding by year
EUR raised per yearResistell Ag — funding by year — interactive chart.
Data table
| Resistell Ag — funding by year | |
|---|---|
| 2019 | €3.2M |
| 2020 | €3.3M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ 8y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-01-15 | Series A | €3.3M | OCCIDENT | View deal → |
| 2020-01-01 | Other | €3.2M | OCCIDENT | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData